USD 0.0
(-50.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -1.47 Million USD | -1025.02% |
2022 | 159.6 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - USD | 100.0% |
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2023 Q2 | 1670.00 USD | 0.0% |
2023 FY | -1.47 Million USD | -1025.02% |
2023 Q4 | -4.58 Million USD | -9967450.0% |
2023 Q3 | 46.00 USD | -97.25% |
2023 Q1 | - USD | -100.0% |
2022 Q4 | 148.37 Thousand USD | 1220.61% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | 11.23 Thousand USD | 0.0% |
2022 FY | 159.6 Thousand USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acutus Medical, Inc. | -3.13 Million USD | 52.936% |
Biotricity, Inc. | 8.35 Million USD | 117.668% |
Cell MedX Corp. | - USD | Infinity% |
Dynatronics Corporation | 7.63 Million USD | 119.337% |
PetVivo Holdings, Inc. | 739.52 Thousand USD | 299.64% |
RetinalGenix Technologies Inc. | -100.00 USD | -1476292.0% |
Sonendo, Inc. | 10.72 Million USD | 113.77% |
Telesis Bio, Inc. | 16.95 Million USD | 108.71% |
Talis Biomedical Corporation | 371 Thousand USD | 497.949% |
Viveve Medical, Inc. | 620 Thousand USD | 338.128% |